MycoMeditations is redefining what a psychedelic retreat can be. Therapeutic immersion with extensive therapy, individualized dosing, and a full week of embedded clinical support changes what working with psilocybin can accomplish.
Wellness travel has produced no shortage of psychedelic retreat options in recent years. What it has produced far less of are programs with the clinical infrastructure to match the goals of the people attending them.
MycoMeditations, operating on Jamaica’s south coast since 2014, is what that infrastructure actually looks like: a licensed therapy team that works with retreat guests through private psilocybin therapy sessions and extensive integration, who are present and available on-site both day and night throughout the entire week. It’s a psilocybin retreat where guests are immersed in an intensive therapy protocol for a full week.
As wellness tourism has shifted into one of travel’s fastest-growing categories, so has the psychedelic retreat industry, with wildly varying offerings and results. MycoMeditations occupies a position of its own within this psychedelic retreat landscape — closer to what concierge medicine is to general healthcare than to anything the term “psychedelic retreat” typically suggests.
As a psychedelic retreat, MycoMeditations “essentially creates total therapeutic immersions, using psilocybin as the catalyst, with full support alongside each guest”, Mike Ljubsa, co-owner, told Ethos.
The retreat
The program runs eight days, includes three psilocybin sessions, and maintains a facilitator-to-guest ratio that never drops below 1:1.5. The therapy team is composed of licensed marriage and family therapists, licensed clinical social workers, and licensed mental health counselors, most with a decade or more of clinical experience. They are present not just for the psilocybin therapy sessions, but for all moments of the retreat, from formal integration to meals and private discussions over the entire week. Around 25 percent of guests return for additional retreats — a figure that reflects the results of guests who first arrived with serious intentions.
Guests who find their way to MycoMeditations are looking for alternatives to what most other psychedelic retreats often consist of: facilitators who adopt the aesthetic and language of working with these medicines without the clinical training to support it at its deeper levels, and retreat formats that gesture toward deep work without the infrastructure to actually go there. Most retreat programs rely on restorative practices like yoga, breathwork, or meditation to help guests regulate and relax between sessions, leaving the deeper therapeutic processing to the individual.
MycoMeditations is built on a different finding: the most significant breakthroughs with psychedelics happen through immersive therapeutic work with trained and experienced practitioners, alongside other people undergoing the same intensive process.
The importance of set and setting
The three waterfront properties on Jamaica’s south coast, where the programs run, were chosen from dozens of locations evaluated over the years, specifically selected for seclusion, scale, and an environment that adds no friction between guests and the work.
After years in the luxury hospitality space, Director of Operations, Abbie Townsend, leads a dedicated concierge team to handle every logistical detail of the week so guests can focus on MycoMeditations’ extensive, in-depth therapy process. She has spent years working directly with the local support staff on all properties to maintain the highest level of service, attention, and care, which is incredibly important to the special needs of the MycoMeditations’ guests.
Psilocybin and integration sessions
MycoMeditations’ integration sessions each last around four hours and are designed with a unique hybrid therapeutic format: each guest works with the lead therapist one at a time, for up to 30 minutes, while the rest of the group is present. Being genuinely witnessed while doing difficult psychological work — not observed, but seen — produces a kind of repatterning that private integration or loose group work don’t tend to achieve. Vulnerability gets relearned as safe in real time, in front of others doing the same. For those with unhealthy attachment patterns, this can be extraordinarily healing. “To work this closely with psychedelic therapists over an entire week of psilocybin therapy alongside others is the peak of how to work with these medicines,” Ljubsa says.
While formal integration is done as a group, the psilocybin sessions are private, which is another major difference between MycoMeditations and other psychedelic retreats. Most retreat programs run group experiences in shared spaces — a format that can make guests self-conscious, spread facilitators too thin across too many people, and create pressure to suppress whatever needs to be processed. At MycoMeditations, guests are thoughtfully placed in designated dosing spaces around the property with a dedicated facilitator for the full session. The high facilitator-to-guest ratio makes that possible, and this privacy helps guests drop even deeper into the psilocybin experience, creating significant therapeutic outcomes. “MycoMeditations gives people the best of both worlds: group dynamics for healing with others, with the space to have these powerful experiences in private,” Ljubsa says.
The method starts with the team
MycoMeditations team members earn their spots through an unusually demanding route. Before any therapist or facilitator is fully brought on board, they complete a minimum of six retreats as a Facilitator-in-Training — observing at least 18 psilocybin group sessions, amounting to around 200 individual psilocybin sessions and over 100 hours of preparation and integration discussions. They attend pre-retreat meetings where each guest’s case is reviewed, and post-retreat debriefs where the team examines what worked and what can improve.
The three-session structure across eight days is a calibrated decision. Single-dose experiences amount to a best guess at a person’s therapeutic threshold; two-dose programs allow for one adjustment. With three sessions, the first reads how a guest actually responds to a moderate dose, and the second and third are dialed in from there toward what the program calls a therapeutically optimized dose — one that tends to run higher than most guests anticipate, and higher than most programs are structured to support.
With the therapeutic experience, clinical staff, constant monitoring, and protocols specifically developed for that range, MycoMeditations considers the three-session week the perfect balance for a psilocybin retreat. Two sessions don’t provide enough opportunity to find and work with the optimal dose, and four psilocybin experiences are often unnecessary, as people reach a healthy limit after three deep sessions, which the company observed after testing four-dose retreats in its early years. Ljubsa says that after witnessing thousands of psilocybin therapy sessions firsthand, the flexibility to find that sweet spot when it comes to a dose is “what makes these extended psychedelic immersions important,” he says, “and it’s what makes MycoMeditations unique.”
Related on Ethos:
